Bobbi Tosh
Family · Batesville, ARNPI 1104342799
Payments from drug & device makers
Across 206 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$857
- Novo Nordisk$500
- Amgen$288
- Lilly USA, LLC$287
- Pfizer$255
- AbbVie$226
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,478100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $857 |
| Novo Nordisk | 31 | $500 |
| Amgen | 18 | $288 |
| Lilly USA, LLC | 19 | $287 |
| Pfizer | 16 | $255 |
| AbbVie | 11 | $226 |
| Abbott | 10 | $197 |
| Boehringer Ingelheim | 11 | $157 |
| Merck | 8 | $120 |
| Astellas Pharma US Inc | 4 | $62 |
| Novartis | 4 | $59 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| GSK | 3 | $51 |
| Exact Sciences | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Lundbeck LLC | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Dexcom, Inc. | 2 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Bayer | 1 | $13 |
| Scynexis, Inc. | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
How this compares
$3,489 in reported general payments places this provider in the 85th percentile of 2,103 family providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 93 | $114,174 |
| JardianceEmpagliflozin | 127 | $107,006 |
| FarxigaDapagliflozin Propanediol | 61 | $49,863 |
| TrulicityDulaglutide | 31 | $31,241 |
| MounjaroTirzepatide | 21 | $28,711 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $23,589 |
| LinzessLinaclotide | 20 | $22,072 |
| JanuviaSitagliptin Phosphate | 25 | $17,777 |
| TradjentaLinagliptin | 26 | $15,378 |
| Repatha SureclickEvolocumab | 20 | $15,378 |
| EliquisApixaban | 26 | $14,837 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $14,170 |
| XareltoRivaroxaban | 20 | $12,596 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $10,907 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 30 | $10,560 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $157 | $122,385153 claims |
| Novo NordiskOzempic | $500 | $114,17493 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $857 | $64,02591 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $287 | $59,95252 claims |
| GSKTrelegy Ellipta, Arexvy, Anoro Ellipta | $51 | $40,56176 claims |
| MerckJanuvia, Janumet, Janumet Xr | $120 | $38,09452 claims |
| AbbVieLinzess, Synthroid | $226 | $23,60748 claims |
| PfizerEliquis | $255 | $14,83726 claims |
| NovartisEntresto | $59 | $7,42311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,103 family providers in Arkansas.
Other family in Batesville
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
- Shelby CochranFayetteville$23K
- Michael StirlingLittle Rock$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.